Need Help?
info@medtechtalents.com
Home
Courses
Drug Safety & Pharmacovigilance
Medical Device Safety
Regulatory Writing
Free Lessons
Career Consulting
Educational Tools
All tools
Causality assessment
Case processing & reporting
Signals, benefit–risk & labelling
Drug-induced conditions
Medical device safety
Clinical research & trials
Biostatistics & evidence
Career & study skills
Book workbenches
Books
All books
Pharmacovigilance & drug safety
Medical device safety
Regulatory writing
Careers in industry
About
Contact
Blog
Communications Interactive Decision Assistant
Home
Communications Interactive Decision Assistant
Lesson 10 Decision Assistant — Communicating, Policy, Real‑World Application
Lesson 10 Decision Assistant
10.1 Communicating Findings · 10.2 Policy Impact · 10.3 Real‑World Application
10.1 Communication
10.2 Policy
10.3 Real‑World
⎇ Tips:
1
/
2
/
3
switch ·
Ctrl
+
S
save ·
Ctrl
+
O
load
Project & Audience
IMRaD · Conferences · Media
Study title
Primary audience
Scientific community
Healthcare professionals
General public / media
Condition / domain
Key headline finding
Funding & conflicts (transparency)
Key limitations
Generate Communication Assets
IMRaD Manuscript Outline
Conference Abstract
Poster Headline & Sections
Press Release (Plain‑Language)
Social Pack (infographic copy)
Copy
Download .txt
Print
Ethics & Accuracy checklist
Avoids overstating efficacy; uses absolute & relative effects where possible
Reports negative/non‑significant findings
Discloses funding & conflicts of interest
Respects participant privacy; no identifying details
Aligns with journal/venue formatting guidelines
Policy Context
Evidence Synthesis · Guidelines · Formulation
Public health issue
Jurisdiction / body
Target population
Costs / feasibility notes
Generate Policy Brief & Tools
1‑Page Policy Brief
Stakeholder Map
KPIs & Evaluation Plan
Copy
Download .txt
Print
Equity & Transparency guardrails
Addresses equity impact; avoids disproportionate burden
Discloses uncertainties & limitations in evidence
Includes implementation feasibility & cost considerations
Implementation Setup
Guidelines · Protocols · Education
Care setting
Key resources / constraints
Primary outcomes / metrics
Rollout timeline (weeks)
Generate Implementation Assets
Protocol Outline
RACI & Roles
Rollout Plan
Evaluation & Feedback Loop
Copy
Download .txt
Print
Privacy & Ethics
Patient data de‑identified in training & evaluation artifacts
Informed consent considered for quality improvement where required
Secure storage & access control for any shared data
IMRaD Manuscript Outline — {{title}} Introduction • Clinical background: {{condition}} • Gap addressed: {{limitations}} • Objective: Summarize key aim and hypothesis. Methods • Design: RCT/observational (specify) • Population: Inclusion/exclusion; setting • Intervention/comparator: Dosing, duration • Outcomes: Primary/secondary (pre‑specified) • Statistics: Power, analysis set • Ethics: IRB approval; consent; data monitoring Results • Primary outcome: {{keyFinding}} • Secondary outcomes: Key signals • Safety: AEs/SAEs summary; notable events • Subgroups/sensitivity analyses Discussion • Interpretation vs. literature • Strengths & limitations: {{limitations}} • Clinical implications for {{audienceLabel}} • Future work & data sharing Transparency • Funding/conflicts: {{funding}}
Conference Abstract — {{title}} Background: Brief context on {{condition}} and unmet need. Methods: Design, sample size, key outcomes. Results: Headline finding — {{keyFinding}}. Include absolute and relative effects if available. Conclusions: Implications for {{audienceLabel}}; limitations ({{limitations}}). Keywords: {{condition}}, clinical trial, safety, effectiveness
Poster Headline “{{keyFinding}} in {{condition}}” Sections • Intro: Need & objective • Methods: Diagram of design • Results: Forest/Bar charts (spaceholders) • Safety: AE/SAE table • Takeaways for {{audienceLabel}} • Transparency: {{funding}} • QR: Preprint/data repository
Plain‑Language Press Release — {{title}} • What we studied: {{condition}} • What we found: {{keyFinding}} (explain simply; add absolute numbers where possible) • What it means: How patients/providers may use this information • What we don’t know yet: {{limitations}} • Who funded it: {{funding}} • Where to learn more: Link to paper/registry
Social Pack (Thread/Carousel) 1) Headline: {{keyFinding}} in {{condition}} 2) Why it matters (1 sentence) 3) Who was studied (n, key traits) 4) What changed (primary outcome) 5) Safety snapshot (AEs/SAEs) 6) Caveats: {{limitations}} 7) Link to full study + conflicts: {{funding}}
One‑Page Policy Brief — {{policyIssue}} Problem • Who is affected? {{targetPop}} • Burden & inequities (concise statistics) Evidence Summary • Key finding: {{keyFinding}} • Strength of evidence, uncertainties: {{limitations}} Recommendations • Actionable steps for {{jurisdiction}} • Feasibility & costs: {{costs}} • Equity safeguards for {{targetPop}} Implementation • Lead agency; partners; timeline • Monitoring KPIs (see plan) Transparency • Funding/conflicts: {{funding}}
Stakeholder Map — {{policyIssue}} • Policymakers: {{jurisdiction}} • Providers & professional orgs • Payers & purchasers • Communities & patient groups (esp. {{targetPop}}) • Industry & tech vendors • Academia & evaluators Engagement Plan • Briefings; consultations; public comment • Co‑design with affected communities
KPIs & Evaluation Plan — {{policyIssue}} Readiness KPIs • Adoption rate of guideline (%) • Training completion (%) Outcome KPIs • Primary clinical metric: {{metrics}} • Safety: AEs/SAEs related to change • Equity: Gap reduction across subgroups Learning System • Review cadence, data sources, feedback loops
Protocol Outline — Setting: {{setting}} 1. Guideline Linkage: Which evidence/guidelines are used 2. Eligibility & Workflow: Inclusion/exclusion; steps 3. Intervention Details: What, who, when 4. Safety Monitoring: Triggers; escalation path 5. Patient Education: Handouts; teach‑back 6. Data Capture: Fields; privacy controls 7. Risks/mitigation: Based on {{resources}}
RACI & Roles — Setting: {{setting}} • Responsible (R): Frontline staff implementing tasks • Accountable (A): Clinical lead/manager • Consulted (C): Pharmacy, IT, Quality • Informed (I): Patients, caregivers, leadership Notes: Resource constraints — {{resources}}
Rollout Plan ({{timeline}} weeks) — Setting: {{setting}} Weeks 1–2: Prep — train staff; finalize materials; test in sandbox Weeks 3–4: Pilot — small cohort; daily huddles; capture issues Weeks 5–6: Expand — refine; add sites/shifts; monitor KPIs ({{metrics}}) Weeks 7–{{timeline}}: Scale & sustain — audits; refresher training; celebrate wins
Evaluation & Feedback Loop — Outcomes: {{metrics}} • Data Sources: EHR, registry, patient‑reported outcomes • Schedule: Monthly review; quarterly deep‑dive • Methods: Run charts; SPC; qualitative feedback • Actions: PDSA cycles; share lessons; update protocol
Menu